Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Structured education for patients with primary brain tumors and their caregivers

Official title: The Effect of the Education for Brain Tumor Patients and Their Caregivers on the Quality of Life and Care Burden

Run by Istanbul University - Cerrahpasa · NCT07617168 · Data updated 2026-11-12

This study tests whether a structured education program for adults with primary brain tumors and their caregivers improves quality of life and reduces caregiver burden.

More Brain Neoplasms trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment72 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedMarch 25, 2026
Main results expectedJanuary 31, 2027
Study endsDecember 31, 2027
Registry record updatedJune 2, 2026
Trial IDNCT07617168 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (>18) with primary brain tumors undergoing their first surgery, fluent in Turkish, and their primary caregivers who meet criteria.

Probably not a fit

Patients or caregivers with severe comorbidities or who are unable to participate in education sessions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial investigates a structured training program based on the Life Model in Nursing for patients with primary brain tumors and their caregivers. It compares this structured education to standard education in terms of patient quality of life and symptom burden. Eligible participants include adults undergoing initial brain tumor surgery and their primary caregivers in Istanbul, Turkey. Outcomes focus on patient-reported quality of life and symptom severity, with education delivered by nursing staff. The study aims to inform nursing practices and caregiver support strategies in neuro-oncology care.

Why it matters

Potential benefit: If successful, patients and caregivers may experience better quality of life and lower caregiver burden through improved knowledge and coping strategies.

How similar studies have gone: Prior nursing interventions for brain tumor patients suggested improvements in well-being and caregiver burden, but education-focused trials remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

For Patients

* Aged \>18 years
* Undergoing primary brain tumor surgery for the first time
* Glasgow Coma Scale score of 15
* Able to assess and express symptoms
* Literate in Turkish
* No psychiatric history
* Not using psychiatric medication
* Willing to participate and provide consent

For Caregivers

* Aged \>18 years
* Primary caregiver providing care for at least 3 months
* Open to communication and cooperation
* No psychiatric history
* Not using psychiatric medication
* Willing to participate and provide consent

Exclusion Criteria

* Not meeting the inclusion criteria
* Intubated patients
* Patients with metastatic brain tumors
* Patients with pituitary tumors

Where it's running

  • Istanbul Basaksehir Cam and Sakura City Hospital
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Merve Nur N Demiryürek — Istanbul University- Cerrahpasa Institute of Graduate Studies
  • Study coordinator: Merve Nur Demiryürek, MSc Student
  • Email: mervenurdemir16@gmail.com
  • Phone: +90 534 065 73 48

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.